Shachi Pandya, MD
Sports Medicine · Homewood, ILNPI 1164817334
Payments from drug & device makers
Across 170 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$736
- Novo Nordisk$480
- Pfizer$264
- Johnson & Johnson$209
- GSK$183
- AstraZeneca$171
- plus $950 from 14 others
What the payments were for
- Food & beverage$2,96999%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 40 | $736 |
| Novo Nordisk | 27 | $480 |
| Pfizer | 17 | $264 |
| Johnson & Johnson | 10 | $209 |
| GSK | 10 | $183 |
| AstraZeneca | 10 | $171 |
| Sanofi-aventis U.S. LLC | 10 | $168 |
| Boehringer Ingelheim | 9 | $157 |
| Novartis | 7 | $116 |
| Bayer | 5 | $115 |
| Amgen | 7 | $93 |
| Currax Pharmaceuticals LLC | 5 | $70 |
| Medtronic | 2 | $53 |
| Merck | 2 | $39 |
| Dexcom, Inc. | 2 | $39 |
| Agile Therapeutics, Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $23 |
| Genentech USA, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $13 |
How this compares
$2,993 in reported general payments places this provider in the 60th percentile of 233 sports medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 149 | $297 |
| Cyclobenzaprine Hcl | 20 | $112 |
| Prednisone | 22 | $46 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Homewood
- Benjamin DombDes Plaines$18.1M
- Gregory NicholsonChicago$6.7M
- Grant GarriguesChicago$3.1M
- Brian ColeChicago$3.1M
- Brian ForsytheChicago$2M
- Nikhil VermaChicago$1M
- Shane NhoChicago$668K
- Adam YankeChicago$388K
- Jason KohSkokie$227K
- Jourdan CancienneJoliet$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.